Thursday, 22 June 2023

Wellness Tourism Market Size Worth $2.1 Trillion By 2030


The global Wellness Tourism Market size is expected to reach USD 2.1 trillion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.42% from 2023 to 2030. Improving patient awareness about health and personal care will be one of the major drivers for the market. Promotional campaigns arranged by various governments are also encouraging wellness tourism across the globe. Wellbeing services offered by players help customers find solutions to improve or maintain their personal health and wellness. The rising number of health-conscious people is contributing to the increasing demand for wellness activities at popular travel destinations.

Wellness tourism includes various activities such as spas, mineral springs, skiing, hiking, Pilates, yoga, and others. In recent years, increasing demand for wellness therapies has resulted in a rise in the number of spas, mineral springs, and wellness retreats. According to the Global Wellness Institute, the number of spa establishments worldwide increased by 7.3% from 149,252 in 2017 to 160,100 in 2020. Furthermore, the number of thermal/mineral spring establishments increased by 352 from 2017 to 2020. This, in turn, has resulted in a rise in employment opportunities. Hence, an increase in the number of spas along with their revenue contribution is expected to drive the market over the forecast period.

With work from anywhere becoming the new normal, people are taking wellness vacations to resorts where they can work while enjoying nature’s beauty. Popular tourism destinations are providing all the facilities to allow working professionals to grow their business prospectus through remote workcations. Countries such as Mexico, Costa Rica, and Bali are building their infrastructure, reputation, and marketing to provide a curated experience for work & travel. Furthermore, the growing prevalence of mental illnesses such as depression and anxiety, rise in disposable income, increasing adoption of online travel services, and growing influence of social media is propelling the market growth.

Moreover, people are now more concerned than ever about their health because of the COVID-19 pandemic. The development of healthy habits remains a top priority, according to research conducted by Mindshare, which found that people's perspectives on their overall health are influenced by the daily assessment of their own health. Sixty-six percent of the global population is now more concerned with their overall health than they were before COVID-19. Furthermore, according to a study conducted by MiQ in collaboration with Sapio Research, over 20% of consumers in the U.S., the U.K., and Australia spent more money on wellness services during the lockdown.

Related Press Release@ Wellness Tourism Market Report

List of Key Players in the Wellness Tourism Market

  • Hilton
  • Accor
  • Hyatt Corporation
  • Rancho La Puerta, Inc.
  • Marriot International, Inc.
  • Rosewood Hotel Group
  • Niraamaya Wellness Retreat
  • InterContinental Hotels Group
  • Omni Hotels & Resorts
  • Radisson Hospitality
  • Four Seasons Hotels Limited

 

Wellness Tourism Market Report Highlights

  • In terms of service, the lodging segment dominated the wellness tourism market in 2022. This can be attributed to the rapid expansion of huge hotel chains that provide exotic therapies including rejuvenation programs, spa treatments, and other services
  • Based on travel type, the domestic segment accounted for the maximum market share in 2022. This can be attributed to increased expenditure by domestic tourists on wellness activities
  • North America is estimated to dominate the market throughout the forecast period. This can be attributed to the high demand for physical and mental health improvement, increasing disposable income, and growing awareness about spa benefits
  • In May 2022, Hilton announced a collaboration with CKR Resort to introduce its flagship brand Hilton Hyderabad Resort & Spa in Hyderabad
  • Marriott International launched a hotel development program named “Marriott's Bridging the Gap" in June 2022

Wellness Tourism Market Report Scope

Report Attribute

Details

The market size value in 2023

USD 923.6 billion

The revenue forecast in 2030

USD 2.1 trillion

Growth Rate

CAGR of 12.42% from 2023 to 2030

The base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

 

Related Reports@

Sports Tourism Market

Medical Tourism Market

Wellness Tourism Market Segmentation

Grand View Research has segmented the global wellness tourism market on the basis of service, travel purpose, travel type, and region:

Travel Purpose Outlook (Revenue, USD Billion, 2018 - 2030)

  • Primary
  • Secondary

Service Outlook (Revenue, USD Billion, 2018 - 2030)

  • In-country Transport
  • Lodging
  • Food & Beverage
  • Wellness Activities
  • Shopping
  • Others

Travel Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Domestic
  • International

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
    • Malaysia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Wednesday, 14 June 2023

Telehealth Market: Industry Demand, Analysis And Future Trends 2030


The global Telehealth Market size is expected to reach USD 455.26 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 24.0% over the forecast period. The rising penetration of the internet and the evolution & development of smartphones are factors that contribute to the growth of the industry. Advancements in digital infrastructure allow users to monitor their health and fitness, avail of medical assistance, and book appointments. For instance, several applications and platforms, such as Doctor on Demand, Lemonaid, and MDLive, allow their users to book appointments, monitor personal health, track consultations, and store healthcare information.

Moreover, the COVID-19 pandemic accelerated the adoption of telemedicine and teleconsultation. The pandemic exposed the shortcomings in the healthcare systems while also burdening the healthcare resources and facilities, which accelerated the adoption of the solutions. The government-imposed travel restrictions and lockdowns to curb the spread of the virus, which led to patients and healthcare institutions shifting toward teleconsultations and telemedicine. In addition, insurance companies and healthcare payers are collaborating with key industry players to provide free consultation services to patients. For instance, AIG and Cigna announced a partnership with Doctor Anywhere in Singapore.

Under this partnership, the companies will provide free consultation services to patients across Thailand, Singapore, and Vietnam. Moreover, the rising number of public-private partnerships, advancements in digital infrastructure, rise in government initiatives, and growing advancements in digital health technologies are anticipated to boost the demand for virtual care applications and services. Several key players, such as GlobalMed, Siemens Healthineers, and Doctor Anywhere, reported a significant rise in revenues and active users during the pandemic. The services segment held the largest share of the global revenue in 2022 due to the rising preference for telemedicine and teleconsultation to reduce healthcare costs and physical visits to hospitals.

Moreover, the development of digital infrastructure is expected to boost the growth of the services segment. The web-based delivery mode segment dominated the global industry in 2022 on account of the higher adoption of web-based solutions by patients and healthcare institutions. The healthcare providers end-use segment accounted for the highest share of the overall revenue in 2022. The high share of this segment can be attributed to the increased adoption of teleconsultation and telemedicine platforms by providers to reduce the burden on healthcare resources and facilities.

Related Press Release@ Telehealth Market Report

Telehealth Market Report Highlights

  • In 2022, the services segment held the largest revenue share due to the advancements in digital healthcare infrastructure along with the increased adoption of telehealth services to manage chronic conditions & monitor health
  • In 2022, the web-based delivery mode segment held the largest revenue share due to the high adoption of web-based solutions by healthcare professionals and patients
  • In 2022, the providers segment held the maximum revenue share due to increased convenience offered by the telehealth services and improved workflow management
  • In 2022, the radiology segment led the industry. However, the psychiatry segment is anticipated to grow at the fastest CAGR over the forecast period owing to increased cases of anxiety, stress, and mental illnesses
  • In 2022, North America was the leading region due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

Related Reports
Telehealth Services Market

Telerehabilitation Market

Telehealth Market Segmentation

Grand View Research, Inc. has segmented the global telehealth market on the basis of product type, delivery mode, end-use, disease area, and region:

Telehealth Product Type Outlook (Revenue, USD Million, 2016 - 2030)

  • Hardware
    • Monitors
    • Medical Peripheral Devices
    • Blood Pressure Meters
    • Blood Glucose Meters
    • Weighing Scales
    • Pulse Oximeters
    • Peak Flow Meters
    • ECG Monitors
    • Others
  • Software
    • Standalone Software
    • Integrated Software
  • Services
    • Remote Patient Monitoring
    • Real-Time Interactions
    • Store and Forward
    • Others

Telehealth Delivery Mode Outlook (Revenue, USD Million, 2016 - 2030)

  • On-premise
  • Web-based
  • Cloud-based

Telehealth End-use Outlook (Revenue, USD Million, 2016 - 2030)

  • Payers
  • Providers
  • Patients

Telehealth Disease Area Outlook (Revenue, USD Million, 2016 - 2030)

  • Psychiatry
  • Substance Use
  • Radiology
  • Endocrinology
  • Dermatology
  • Gastroenterology
  • Neurological Medicine
  • ENT
  • Cardiology
  • Oncology
  • Dental
  • Gynecology
  • General Medicine
  • Others

Telehealth Regional Outlook (Revenue, USD Million, 2016 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Belgium
    • The Netherlands
    • Luxembourg
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Chile
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Monday, 12 June 2023

Biomarkers Market By F. Hoffmann-La Roche Ltd.; Abbott; Epigenomics AG; General Electric; Johnson & Johnson Services, Inc.

 


The global Biomarkers Market size is expected to reach USD 181.03 billion by 2030, registering a CAGR of 13.3% over the forecast period, according to a new report by Grand View Research, Inc. The rising R&D investments by pharmaceutical and biotechnology companies, increasing number of Contract Research Organizations(CROs), and declining cost of clinical trials in emerging economies are the major driving factors for the industry. In addition, key players leverage various strategies to increase their production capabilities and promote the outreach of their product offerings. In June 2022, Paige announced its collaboration with Janssen to evaluate the potential of an (H&E)-based, (AI)-powered biomarker test, developed by Janssen, to screen for actionable FGFR3 and FGFR2 genomic alterations in patients with bladder cancer.

The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders is anticipated to fuel industry growth. According to the American Cancer Society, in 2022, an estimated 1.9 million new cancer cases were registered in the U.S., accounting for 609,360 deaths. Breast and lung cancers were observed as the most common ones worldwide. In addition, according to a report published in 2020 by the Institute for Health Metrics and Evaluation, cardiovascular diseases cause about 18.9 million deaths annually. Increasing research focused on the identification of new diagnostic biomarkers is fueling the industry's growth. For instance, in February 2022, Japanese scientists found two new diagnostic tissue biomarkers, PHGDH and TRIM29, indicated for malignant pleural mesothelioma.

These agents can be used to diagnose mesothelioma quickly and help doctors in differentiating between mesothelioma and other cancers. Moreover, in January 2020, a nascent research study published in the Journal of Nuclear Medicine discussed the potential of several breast cancer biomarkers. A notable and easily identifiable imaging biomarker recognized in the study was 18F-FDG PET. Moreover, the COVID-19 pandemic has encouraged the use of biomarkers for facilitating the detection & treatment of the disease. For instance, in March 2021, a new biomarker-based screening device, named Tiger Tech COVID Plus Monitor, was approved by the U.S. FDA.

The device can be used for the identification of biomarkers for COVID-19 and other hypercoagulable & hyperinflammatory conditions in individuals aged 5 years & above. Furthermore, various strategic initiatives undertaken by leading participants are anticipated to cater to demand. For instance, in August 2022, Roche received the U.S. FDA approval for VENTANA MMR RxDx Panel to detect pMMR endometrial cancer patients and dMMR solid tumor patients eligible for treatment with Merck’s immunotherapy Keytruda. This approval for the VENTANA MMR RxDx Panel is a label expansion of the company’s recent on-market panel. Also, in December 2021, Siemens Healthineers partnered with Freenome to identify novel suitable markers for the detection of early breast cancer to expand its existing imaging technologies.

Related Press Release@ Biomarkers Market Report

Biomarkers Market Report Highlights

  • The safety segment held the largest share in 2022 owing to the increased adoption of safety biomarkers in drug discovery and development
  • The efficacy segment will register the fastest growth rate from 2023 to 2030 due to a rise in strategic collaborations for promoting research activities
  • The drug discovery & development segment accounted for the largest share in 2022 due to the extensive R&D efforts taken by leading participants, and the rising adoption of biomarkers in drug discovery
  • The cancer disease segment dominated the industry in 2022. However, the neurological diseases segment is anticipated to record the fastest CAGRover the forecast years
  • Asia Pacific is expected to be the fastest-growing region over the forecast period due to the rising investments by key players and increasing disease prevalence in the region

Related Reports
Cardiac Biomarkers Market

Cancer Biomarker Market

Biomarkers Market Segmentation

Grand View Research has segmented the global biomarkers market based on type, application, disease, and region:

Biomarkers Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Safety
  • Efficacy
  • Validation

Biomarkers Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Others

Biomarkers Disease Outlook (Revenue, USD Billion, 2018 - 2030)

  • Cancer
    • Safety
    • Efficacy
    • Validation
  • Cardiovascular Diseases
    • Safety
    • Efficacy
    • Validation
  • Neurological Diseases
    • Safety
    • Efficacy
    • Validation
  • Immunological Diseases
    • Safety
    • Efficacy
    • Validation
  • Others
    • Safety
    • Efficacy
    • Validation

Biomarkers Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Friday, 2 June 2023

Ambulatory Surgery Center Market Size Worth $120.8 Billion By 2026 | CAGR: 6.1%

 


The global Ambulatory Surgery Centers Market size is expected to reach USD 120.8 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a 6.1% CAGR during the forecast period. Increase in incidence of chronic diseases and rise in geriatric population have furthered the demand for ambulatory surgery centers. Furthermore, advancements in surgeries, such as endoscopy and laparoscopy, are expected to propel ASC market growth.

The number of patient admissions is slowly decreasing owing to increasing outpatient visits. This is primarily due to high hospitalization cost and adoption of technologically advanced techniques in outpatient centers, making treatment fast and cost-effective. Advanced surgical methods allow tests and procedures to be performed without hospital admission. According to the American Hospital Association, the total number of outpatient admissions increased from 624 million in 2008 to 675 million in 2012. The number of inpatient admissions decreased from 35.76 million in 2008 to 34.40 million in 2012.

In May 2016, some new codes were added to the coverage for outpatient services in U.S., such as that for gynecology, adenoidectomy, and tonsillectomy. Hence, supportive reimbursement scenario is anticipated to boost market growth.

North America held the dominant share in 2018, driven primarily by U.S. Leading market players in the country are acquiring ambulatory services to provide technologically advanced surgeries and treatments, further propelling demand for ambulatory and primary care services. Asia Pacific is likely to emerge as a strong contender in the global scenario. Some of the prominent players in this region are Surgery Center of Melbourne, Nova Medical Centers, Kaiser Permanente, The Indian Association of Day Surgery, Memorial Sloan Kettering, M D Anderson Cancer Center, and The Mumbai Surgical Society.

Related Press Release@ Ambulatory Surgery Center Market Report

Top Key players in Ambulatory Surgery Center Market

·         Envision Healthcare Corporation

·         Terveystalo

·         Tenet Healthcare Corporation

·         MEDNAX Services, Inc.

·         TeamHealth

·         Quorum Health Corporation

·         UnitedHealth Group

·         Surgery Partners

·         Community Health Systems, Inc.

·         Healthway Medical Group.

Ambulatory Surgery Center Market Report Highlights

·         In 2018, gastroenterology accounted for the largest share in the market by application. This can be attributed to surge in visits to ambulatory care centers for treatment of gastrointestinal diseases. It is one of the most common surgical specialties in single- or multi-specialty ASCs

  • Plastic surgery is anticipated to observe the fastest growth in the coming years due to rise in disposable income and growing preference for private care facilities in comparison with hospital surgery centers for plastic surgery. Time and cost advantages, as well as expertise offered by these ambulatory centers, are anticipated to boost demand for plastic surgeries in these settings
  • North America dominated the market in 2018 thanks to increased government funding focused on transforming primary care services and rise in coverage for outpatient services
  • Asia Pacific is expected to witness lucrative growth in the coming years owing to presence of developing economies, increasing awareness about ASCs, and investments by international players

Related Reports@

Ambulance Services Market

Aesthetic Medicine Market

Ambulatory Surgery Center Market Segmentation

Grand View Research has segmented the global ambulatory surgery center market by application and region:

ASC Application Outlook (Revenue, USD Million, 2015 - 2026)

  • Ophthalmology
  • Orthopedics
  • Gastroenterology
  • Pain Management/Spinal Injections
  • Plastic Surgery
  • Others

ASC Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • New Zealand
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com



Wound Gel Market Size To Reach $9.68 billion By 2033

  The global wound gel market size was valued at USD 6.05 billion in 2024 and is projected to reach USD 9.68 billion by 2033, growing at a C...